1. Home
  2. PEBO vs ALVO Comparison

PEBO vs ALVO Comparison

Compare PEBO & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp Inc.

PEBO

Peoples Bancorp Inc.

HOLD

Current Price

$34.90

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.37

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEBO
ALVO
Founded
1902
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
PEBO
ALVO
Price
$34.90
$3.37
Analyst Decision
Buy
Buy
Analyst Count
3
4
Target Price
$37.33
$8.00
AVG Volume (30 Days)
144.9K
378.5K
Earning Date
04-21-2026
05-06-2026
Dividend Yield
4.94%
N/A
EPS Growth
N/A
N/A
EPS
0.81
N/A
Revenue
$197,000.00
N/A
Revenue This Year
$17.29
$13.28
Revenue Next Year
$2.97
$18.63
P/E Ratio
$42.93
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$27.49
$3.03
52 Week High
$35.46
$11.85

Technical Indicators

Market Signals
Indicator
PEBO
ALVO
Relative Strength Index (RSI) 57.11 46.87
Support Level $33.56 $3.13
Resistance Level $35.46 $3.74
Average True Range (ATR) 0.60 0.17
MACD 0.09 0.01
Stochastic Oscillator 86.27 29.91

Price Performance

Historical Comparison
PEBO
ALVO

About PEBO Peoples Bancorp Inc.

Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: